
Availability: In Stock
Ozempic® is the brand name for semaglutide when prescribed primarily for type 2 diabetes. It is a once-weekly injectable GLP-1 receptor agonist.saxenda-weight-loss
Approved:
To improve blood sugar control in adults with type 2 diabetes
To lower the risk of heart attack, stroke, or death in adults with type 2 diabetes and established cardiovascular disease
Not officially approved for weight loss, but many patients experience significant weight reduction (that indication is branded separately as Wegovy®).
Ozempic mimics the gut hormone GLP-1 (glucagon-like peptide-1), which:
Stimulates insulin release when blood sugar is high
Reduces glucagon secretion (lowers liver glucose output)
Slows gastric emptying (prolongs fullness)
Acts on the brain to reduce appetite
Injection under the skin (subcutaneous) once a week (stomach, thigh, or upper arm)
Usual titration:
Start: 0.25 mg weekly (not effective for blood sugar, just for tolerability)
Increase to 0.5 mg, then 1 mg
Maximum: 2 mg weekly
Reduces HbA1c by ~1–1.5%
Helps with weight loss (average ~5–10% of body weight in diabetes patients)
Provides cardiovascular protection in high-risk patients
Common (mild, usually improve over time):
Nausea, vomiting, diarrhea, constipation
Loss of appetite
Stomach pain, bloating
Serious (less common):
Pancreatitis (severe abdominal pain)
Gallbladder disease
Kidney problems (from dehydration)
Possible thyroid C-cell tumors (seen in animals → avoid if personal/family history of medullary thyroid carcinoma or MEN2)
Risk of low blood sugar when used with insulin or sulfonylureas
✅ Bottom line: Ozempic is a once-weekly injection for type 2 diabetes that lowers blood sugar, protects the heart, and often leads to weight loss. For weight management specifically (without diabetes), the higher-dose version Wegovy® is prescribed.semaglutide-weight-loss,glp-1-fat-loss-jab,amitriptyline-25mg,victoza-weight-loss.
| QUANTITY | 1 OZ, 2 OZ, 3 OZ, 4 OZ, 5 OZ, 6 OZ |
|---|